Disulfonate stilbenes for use in the treatment of proliferative diseases
US12233041B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 22, 2019 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Feb 24, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C311/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of general formula: wherein R0A and R0B are independently selected from hydrogen and pharmaceutically acceptable cations; and RA and RB are identical and selected from amide, carbamate, sulphonamide, azido, cyano and halide. Also, a pharmaceutical composition including one of the compounds. The composition may also include another active ingredient, especially an antineoplastic agent. Further a compound or a composition for use as a medicament, especially a compound or a composition for use in the treatment of a proliferative disease such as for example cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.